Cargando…

Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review

OBJECTIVES: Non-randomised clinical trial designs involving comparisons against external controls or specific standards can be used to support regulatory submissions for indications in diseases that are rare, with high unmet need, without approved therapies and/or where placebo is considered unethic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goring, Sarah, Taylor, Aliki, Müller, Kerstin, Li, Tina Jun Jian, Korol, Ellen E, Levy, Adrian R, Freemantle, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Pharmacology and Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398650/ https://www.ncbi.nlm.nih.gov/pubmed/30819708 http://dx.doi.org/10.1136/bmjopen-2018-024895

Ejemplares similares

Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999–2014
por: Hatswell, Anthony J, et al.
Publicado: (2016)

Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
por: Cornelius, Victoria R, et al.
Publicado: (2016)

Regulatory approval pathway for COVID-19 vaccine in USA, Europe and India
por: Narasimhan, Jaipratap, et al.
Publicado: (2023)

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study
por: Zeitoun, Jean-David, et al.
Publicado: (2017)

A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study
por: Schjøtt, Jan, et al.
Publicado: (2012)

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study
por: Moore, Thomas J, et al.
Publicado: (2020)

Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States
por: Lee, Mijin, et al.
Publicado: (2023)

Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK
por: Bjerre, Lise M, et al.
Publicado: (2018)

Prevalence of polypharmacy and associated adverse outcomes and risk factors among children with asthma in the USA: a cross-sectional study
por: Xie, Luyu, et al.
Publicado: (2022)

Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs
por: Giannuzzi, Viviana, et al.
Publicado: (2017)

To what extent does sex, age and BMI impact medical and pharmacy costs? A retrospective cohort study involving employees in a large school district in the USA
por: Merrill, Ray M, et al.
Publicado: (2019)

Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities
por: Dombernowsky, Tilde, et al.
Publicado: (2017)

Effects of nicotine mouth spray on urges to smoke, a randomised clinical trial
por: Hansson, Anna, et al.
Publicado: (2012)

Zinc acetate lozenges for the treatment of the common cold: a randomised controlled trial
por: Hemilä, Harri, et al.
Publicado: (2020)

The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis
por: Killin, Lewis O J, et al.
Publicado: (2014)

Lithium for Fracture Treatment (LiFT): a double-blind randomised control trial protocol
por: Nam, Diane, et al.
Publicado: (2020)

Hypertension Analysis of stress Reduction using Mindfulness meditatiON and Yoga (The HARMONY Study): study protocol of a randomised control trial
por: Blom, Kimberly, et al.
Publicado: (2012)

Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial
por: Pride, Natalie A, et al.
Publicado: (2018)

Intravenous ketorolac versus morphine in children presenting with suspected appendicitis: a pilot single-centre non-inferiority randomised controlled trial
por: Eltorki, Mohamed, et al.
Publicado: (2022)

Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study
por: van der Veen, Lucia, et al.
Publicado: (2021)

Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials
por: Noor, Nurulamin M, et al.
Publicado: (2022)

Evaluation of a prescription support-tool for chronic management of oral antithrombotic combinations in adults using clinical vignettes: protocol of a randomised controlled trial
por: Zerah, Lorene, et al.
Publicado: (2019)

Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT—protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial
por: Kerckhove, Nicolas, et al.
Publicado: (2016)

Randomised, double-blind, parallel group, placebo-controlled study to evaluate the analgesic efficacy and safety of VVZ-149 injections for postoperative pain following laparoscopic colorectal surgery
por: Nedeljkovic, Srdjan S, et al.
Publicado: (2017)

Cannabidiol (CBD) and Δ(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
por: Suraev, Anastasia, et al.
Publicado: (2020)

Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial
por: Kiguba, Ronald, et al.
Publicado: (2022)

Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial
por: Kjellberg, Anders, et al.
Publicado: (2022)

Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial
por: Nyang'wa, Bern-Thomas, et al.
Publicado: (2021)

Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee
por: Endo, Makoto, et al.
Publicado: (2023)

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)
por: Hjelmesæth, Jøran, et al.
Publicado: (2018)

Safer medicines To reduce falls and refractures for OsteoPorosis (#STOP): a study protocol for a randomised controlled trial of medical specialist-initiated pharmacist-led medication management reviews in primary care
por: Moles, Rebekah Jane, et al.
Publicado: (2023)

Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
por: Wright, Ellen, et al.
Publicado: (2015)

The PATCH trial: efficacy and safety of 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a study protocol for a multicentric, double-blind, enriched enrolment randomised withdrawal, vehicle-controlled study
por: Zhao, Chunmei, et al.
Publicado: (2021)

Brain connectivity-guided, Optimised theta burst transcranial magnetic stimulation to improve Central Pain Modulation in knee Osteoarthritis Pain (BoostCPM): protocol of a pilot randomised clinical trial in a secondary care setting in the UK
por: Drabek, Marianne, et al.
Publicado: (2023)

Tramadol/dexketoprofen (TRAM/DKP) compared with tramadol/paracetamol in moderate to severe acute pain: results of a randomised, double-blind, placebo and active-controlled, parallel group trial in the impacted third molar extraction pain model (DAVID study)
por: Gay-Escoda, Cosme, et al.
Publicado: (2019)

Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT)
por: MacDonald, Thomas M, et al.
Publicado: (2013)

Systematic literature review and network meta-analysis in highly active relapsing–remitting multiple sclerosis and rapidly evolving severe multiple sclerosis
por: Huisman, Eline, et al.
Publicado: (2017)

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
por: Christensen, Alexander S., et al.
Publicado: (2020)

DPP-4 Inhibitor and Sulfonylurea Differentially Reverse Type 2 Diabetes–Induced Blood–Brain Barrier Leakage and Normalize Capillary Pericyte Coverage
por: Elabi, Osama F., et al.
Publicado: (2023)

INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trial
por: Naidoo, Anushka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_45ptvk90jt4vu56cquegdmh92k